A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study

Peer review reports

Original Submission
18 Nov 2009	Submitted	Original manuscript
18 Nov 2009	Author responded	Author comments - Helena Linardou
Resubmission - Version 2
18 Nov 2009	Submitted	Manuscript version 2
Publishing
7 Jan 2010	Editorially accepted
7 Jan 2010	Article published	10.1186/1741-7015-8-3

Back to article page